Giraudo S - Search Results

1

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.

Di Fonzo A, Chien HF, Socal M, Giraudo S, Tassorelli C, Iliceto G, Fabbrini G, Marconi R, Fincati E, Abbruzzese G, Marini P, Squitieri F, Horstink MW, Montagna P, Libera AD, Stocchi F, Goldwurm S, Ferreira JJ, Meco G, Martignoni E, Lopiano L, Jardim LB, Oostra BA, Barbosa ER; Italian Parkinson Genetics Network; Bonifati V. Di Fonzo A, et al. Among authors: giraudo s. Neurology. 2007 May 8;68(19):1557-62. doi: 10.1212/01.wnl.0000260963.08711.08. Neurology. 2007. PMID: 17485642

2

Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.

Aime S, Bergamasco B, Casu M, Digilio G, Fasano M, Giraudo S, Lopiano L. Aime S, et al. Among authors: giraudo s. Mov Disord. 2000 Sep;15(5):977-81. doi: 10.1002/1531-8257(200009)15:5<977::aid-mds1032>3.0.co;2-q. Mov Disord. 2000. PMID: 11009208

3

Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients.

Lopiano L, Chiesa M, Digilio G, Giraudo S, Bergamasco B, Torre E, Fasano M. Lopiano L, et al. Among authors: giraudo s. Biochim Biophys Acta. 2000 Mar 17;1500(3):306-12. doi: 10.1016/s0925-4439(99)00116-7. Biochim Biophys Acta. 2000. PMID: 10699372 Free article.

4

Proteome analysis of human substantia nigra in Parkinson's disease.

Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M. Basso M, et al. Among authors: giraudo s. Proteomics. 2004 Dec;4(12):3943-52. doi: 10.1002/pmic.200400848. Proteomics. 2004. PMID: 15526345

5

Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein.

Fasano M, Giraudo S, Coha S, Bergamasco B, Lopiano L. Fasano M, et al. Among authors: giraudo s. Neurochem Int. 2003 Jun;42(7):603-6. doi: 10.1016/s0197-0186(02)00161-4. Neurochem Int. 2003. PMID: 12590943

6

Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease.

Basso M, Giraudo S, Lopiano L, Bergamasco B, Bosticco E, Cinquepalmi A, Fasano M. Basso M, et al. Among authors: giraudo s. Neurol Sci. 2003 Oct;24(3):155-6. doi: 10.1007/s10072-003-0106-2. Neurol Sci. 2003. PMID: 14598063

7

Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation.

Lopiano L, Fasano M, Giraudo S, Digilio G, Koenig SH, Torre E, Bergamasco B, Aime S. Lopiano L, et al. Among authors: giraudo s. Neurochem Int. 2000 Oct;37(4):331-6. doi: 10.1016/s0197-0186(00)00036-x. Neurochem Int. 2000. PMID: 10825573

8

Magnetic investigations of human mesencephalic neuromelanin.

Bolzoni F, Giraudo S, Lopiano L, Bergamasco B, Fasano M, Crippa PR. Bolzoni F, et al. Among authors: giraudo s. Biochim Biophys Acta. 2002 Mar 16;1586(2):210-8. doi: 10.1016/s0925-4439(01)00099-0. Biochim Biophys Acta. 2002. PMID: 11959462 Free article.

9

Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress.

Mila S, Albo AG, Corpillo D, Giraudo S, Zibetti M, Bucci EM, Lopiano L, Fasano M. Mila S, et al. Among authors: giraudo s. Biomark Med. 2009 Apr;3(2):117-28. doi: 10.2217/bmm.09.4. Biomark Med. 2009. PMID: 20477505

10

alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity.

Colapinto M, Mila S, Giraudo S, Stefanazzi P, Molteni M, Rossetti C, Bergamasco B, Lopiano L, Fasano M. Colapinto M, et al. Among authors: giraudo s. Biochem Biophys Res Commun. 2006 Nov 3;349(4):1294-300. doi: 10.1016/j.bbrc.2006.08.163. Epub 2006 Sep 5. Biochem Biophys Res Commun. 2006. PMID: 16978583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page